Cedric Francois, Chief Executive Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 68,900 shares at $52.07 ($2.9M) on 2022-12-19, disclosed to the SEC on 2022-12-21.
Open-market sale of $2.9M APLS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 12,500 | $0 | 0.0% |
| 2 | $51.97 | 3,751 | $195K | 6.6% |
| 3 | $51.97 | 3,751 | $195K | 6.6% |
| 4 | $52.07 | 24,449 | $1.3M | 43.4% |
| 5 | $52.07 | 24,449 | $1.3M | 43.4% |
| Total | $42.61 avg | 68,900 |
| $2.9M |
| 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $226K | — | Filing → |
| APLS | SELL | 2025-08-29 | $12.7M | — | Filing → |
| APLS | SELL | 2025-07-18 | $797K | — | Filing → |